Pre-emptive DPYD genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients
{{output}}
IntroductionDespite evidence for dose reductions in DPYD variant allele carriers; efficacy concerns remain; we examined survival and dose tolerance in Australian fluoropyrimidine (FP) treated patients.MethodsData originated from the multi-centre PACIFIC-PGx tr... ...
